 Home > Medical News > Latest Medical News > Hanyu Pharmaceutical Etibatide passed the consistency evaluation of generic drugs

Hanyu Pharmaceutical Etibatide passed the consistency evaluation of generic drugs

 Last Update: 2021-09-20
 Source: Internet
 Author: User

Tags

k3 drug

british food company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 26, Hanyu Pharmaceutical issued an announcement saying that it was recently learned through the official website of the State Food and Drug Administration that the company’s eptifibatide injection passed the consistency evaluation of the quality and efficacy of generic drugs, and the consistency of eptifibatide injection The status of the evaluation approved document (acceptance number: CYHB1950135) on the website of the State Food and Drug Administration has been changed to "drug approval certificate pending collection", and the date of issuance is August 18, 2021

The status of "drug approval certificate pending collection" means that the company's eptifibatide injection consistency evaluation has been approved by the State Food and Drug Administration, and the company has not yet received a formal drug approval

Indications of Etibatide Etibatide injection is used in patients with acute coronary syndrome (unstable angina pectoris/non-ST-segment elevation myocardial infarction), including patients receiving medical treatment and percutaneous coronary intervention Patients undergoing PCI to reduce the incidence of the combined endpoint of death or new myocardial infarction; for patients undergoing percutaneous coronary intervention (PCI), including patients undergoing coronary stenting

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.